{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T20:43:37Z","timestamp":1771620217478,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1124\/jpet.106.107599","type":"journal-article","created":{"date-parts":[[2006,8,17]],"date-time":"2006-08-17T00:34:25Z","timestamp":1155774865000},"page":"622-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["The New Low Calcemic Vitamin D Analog 22-Ene-25-Oxa-Vitamin D Prominently Ameliorates T Helper Cell Type 1-Mediated Colitis in Mice"],"prefix":"10.1016","volume":"319","author":[{"given":"Carolin","family":"Daniel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinfried H.","family":"Radeke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico A.","family":"Sartory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Zuegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Steinmeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.107599_bib1","doi-asserted-by":"crossref","unstructured":"Asseman C, Mauze S, Leach MW, Coffman RL, and Powrie F (1999) An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 190: 995\u20131004.","DOI":"10.1084\/jem.190.7.995"},{"key":"10.1124\/jpet.106.107599_bib2","doi-asserted-by":"crossref","unstructured":"Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, Waal-Malefyt R, Coffman RL, Hawrylowicz CM, and O\u2019Garra A (2002) In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195: 603\u2013616.","DOI":"10.1084\/jem.20011629"},{"key":"10.1124\/jpet.106.107599_bib3","doi-asserted-by":"crossref","unstructured":"Bhalla AK, Amento EP, Clemens TL, Holick MF, and Krane SM (1983) Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab 57: 1308\u20131310.","DOI":"10.1210\/jcem-57-6-1308"},{"key":"10.1124\/jpet.106.107599_bib4","doi-asserted-by":"crossref","unstructured":"Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, and O\u2019Garra A (2001) 1\u03b1,25-Dihydroxyvitamin D3 has a direct effect on naive CD4+ T cells to enhance the development of Th2 cells. J Immunol 167: 4974\u20134980.","DOI":"10.4049\/jimmunol.167.9.4974"},{"key":"10.1124\/jpet.106.107599_bib5","doi-asserted-by":"crossref","unstructured":"Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248\u2013254.","DOI":"10.1006\/abio.1976.9999"},{"key":"10.1124\/jpet.106.107599_bib6","doi-asserted-by":"crossref","unstructured":"Bradley PP, Priebat DA, Christensen RD, and Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Investig Dermatol 78: 206\u2013209.","DOI":"10.1111\/1523-1747.ep12506462"},{"key":"10.1124\/jpet.106.107599_bib7","doi-asserted-by":"crossref","unstructured":"Brandtzaeg P, Haraldsen G, and Rugtveit J (1997) Immunopathology of human inflammatory bowel disease. Springer Semin Immunopathol 18: 555\u2013589.","DOI":"10.1007\/BF00824058"},{"key":"10.1124\/jpet.106.107599_bib8","doi-asserted-by":"crossref","unstructured":"Cantorna MT, Zhu Y, Froicu M, and Wittke A (2004) Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr 80: 1717S\u20131720S.","DOI":"10.1093\/ajcn\/80.6.1717S"},{"key":"10.1124\/jpet.106.107599_bib9","doi-asserted-by":"crossref","unstructured":"Carlberg C (2003) Molecular basis of the selective activity of vitamin D analogues. J Cell Biochem 88: 274\u2013281.","DOI":"10.1002\/jcb.10337"},{"key":"10.1124\/jpet.106.107599_bib10","doi-asserted-by":"crossref","unstructured":"Daniel C, Schlauch T, Zugel U, Steinmeyer A, Radeke HH, Steinhilber D, and Stein J (2005) 22-Ene-25-oxa-vitamin D: a new vitamin D analogue with profound immunosuppressive capacities. Eur J Clin Investig 35: 343\u2013349.","DOI":"10.1111\/j.1365-2362.2005.01492.x"},{"key":"10.1124\/jpet.106.107599_bib11","doi-asserted-by":"crossref","unstructured":"DeLuca HF and Cantorna MT (2001) Vitamin D: its role and uses in immunology. FASEB J 15: 2579\u20132585.","DOI":"10.1096\/fj.01-0433rev"},{"key":"10.1124\/jpet.106.107599_bib12","doi-asserted-by":"crossref","unstructured":"Dong X, Craig T, Xing N, Bachman LA, Paya CV, Weih F, McKean DJ, Kumar R, and Griffin MD (2003) Direct transcriptional regulation of RelB by 1\u03b1,25-dihydroxyvitamin D3 and its analogs: physiologic and therapeutic implications for dendritic cell function. J Biol Chem 278: 49378\u201349385.","DOI":"10.1074\/jbc.M308448200"},{"key":"10.1124\/jpet.106.107599_bib13","doi-asserted-by":"crossref","unstructured":"Froicu M, Weaver V, Wynn TA, McDowell MA, Welsh JE, and Cantorna MT (2003) A crucial role for the vitamin D receptor in experimental inflammatory bowel diseases. Mol Endocrinol 17: 2386\u20132392.","DOI":"10.1210\/me.2003-0281"},{"key":"10.1124\/jpet.106.107599_bib14","doi-asserted-by":"crossref","unstructured":"Glimcher LH and Murphy KM (2000) Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev 14: 1693\u20131711.","DOI":"10.1101\/gad.14.14.1693"},{"key":"10.1124\/jpet.106.107599_bib15","doi-asserted-by":"crossref","unstructured":"Griffin MD, Xing N, and Kumar R (2003) Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 23: 117\u2013145.","DOI":"10.1146\/annurev.nutr.23.011702.073114"},{"key":"10.1124\/jpet.106.107599_bib16","doi-asserted-by":"crossref","unstructured":"Hartmann G, Bidlingmaier C, Siegmund B, Albrich S, Schulze J, Tschoep K, Eigler A, Lehr HA, and Endres S (2000) Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice. J Pharmacol Exp Ther 292: 22\u201330.","DOI":"10.1016\/S0022-3565(24)35257-7"},{"key":"10.1124\/jpet.106.107599_bib17","doi-asserted-by":"crossref","unstructured":"Hypponen E, Laara E, Reunanen A, Jarvelin MR, and Virtanen SM (2001) Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 358: 1500\u20131503.","DOI":"10.1016\/S0140-6736(01)06580-1"},{"key":"10.1124\/jpet.106.107599_bib18","doi-asserted-by":"crossref","unstructured":"Mahon BD, Gordon SA, Cruz J, Cosman F, and Cantorna MT (2003) Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 134: 128\u2013132.","DOI":"10.1016\/S0165-5728(02)00396-X"},{"key":"10.1124\/jpet.106.107599_bib19","doi-asserted-by":"crossref","unstructured":"Manolagas SC, Provvedini DM, and Tsoukas CD (1985) Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol 43: 113\u2013122.","DOI":"10.1016\/0303-7207(85)90074-7"},{"key":"10.1124\/jpet.106.107599_bib20","doi-asserted-by":"crossref","unstructured":"Mathieu C and Adorini L (2002) The coming of age of 1,25-dihydroxyvitamin D3 analogs as immunomodulatory agents. Trends Mol Med 8: 174\u2013179.","DOI":"10.1016\/S1471-4914(02)02294-3"},{"key":"10.1124\/jpet.106.107599_bib21","doi-asserted-by":"crossref","unstructured":"Mizwicki MT, Bishop JE, Olivera CJ, Huhtakangas J, and Norman AW (2004) Evidence that annexin II is not a putative membrane receptor for 1\u03b1,25(OH)2-vitamin D3. J Cell Biochem 91: 852\u2013863.","DOI":"10.1002\/jcb.10783"},{"key":"10.1124\/jpet.106.107599_bib22","doi-asserted-by":"crossref","unstructured":"Neurath MF, Finotto S, and Glimcher LH (2002) The role of Th1\/Th2 polarization in mucosal immunity. Nat Med 8: 567\u2013573.","DOI":"10.1038\/nm0602-567"},{"key":"10.1124\/jpet.106.107599_bib23","doi-asserted-by":"crossref","unstructured":"Neurath MF, Fuss I, Kelsall BL, Stuber E, and Strober W (1995) Antibodies to interleukin 12 abrogate established experimental colitis in mice. J Exp Med 182: 1281\u20131290.","DOI":"10.1084\/jem.182.5.1281"},{"key":"10.1124\/jpet.106.107599_bib24","doi-asserted-by":"crossref","unstructured":"Norman AW, Mizwicki MT, and Norman DP (2004) Steroid-hormone rapid actions, membrane receptors and a conformational ensemble model. Nat Rev Drug Discov 3: 27\u201341.","DOI":"10.1038\/nrd1283"},{"key":"10.1124\/jpet.106.107599_bib25","doi-asserted-by":"crossref","unstructured":"Peterlik M and Cross HS (2005) Vitamin D and calcium deficits predispose for multiple chronic diseases. Eur J Clin Investig 35: 290\u2013304.","DOI":"10.1111\/j.1365-2362.2005.01487.x"},{"key":"10.1124\/jpet.106.107599_bib26","doi-asserted-by":"crossref","unstructured":"Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, and Willheim M (2002) 1\u03b1,25(OH)2 d3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res 52: 12\u201318.","DOI":"10.1203\/00006450-200207000-00005"},{"key":"10.1124\/jpet.106.107599_bib27","doi-asserted-by":"crossref","unstructured":"Provvedini DM, Tsoukas CD, Deftos LJ, and Manolagas SC (1983) 1,25-Dihydroxyvitamin D3 receptors in human leukocytes. Science (Wash DC) 221: 1181\u20131183.","DOI":"10.1126\/science.6310748"},{"key":"10.1124\/jpet.106.107599_bib28","doi-asserted-by":"crossref","unstructured":"Revankar CM, Cimino DF, Sklar LA, Arterburn JB, and Prossnitz ER (2005) A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science (Wash DC) 307: 1625\u20131630.","DOI":"10.1126\/science.1106943"},{"key":"10.1124\/jpet.106.107599_bib29","doi-asserted-by":"crossref","unstructured":"Simmons JD, Mullighan C, Welsh KI, and Jewell DP (2000) Vitamin D receptor gene polymorphism: association with Crohn\u2019s disease susceptibility. Gut 47: 211\u2013214.","DOI":"10.1136\/gut.47.2.211"},{"key":"10.1124\/jpet.106.107599_bib30","doi-asserted-by":"crossref","unstructured":"Staeva-Vieira TP and Freedman LP (2002) 1,25-Dihydroxyvitamin D3 inhibits IFN-\u03b3 and IL-4 levels during in vitro polarization of primary murine CD4+ T cells. J Immunol 168: 1181\u20131189.","DOI":"10.4049\/jimmunol.168.3.1181"},{"key":"10.1124\/jpet.106.107599_bib31","doi-asserted-by":"crossref","unstructured":"Steinmeyer A, Kirsch G, Neef G, and Schwarz K (2000) New synthetic vitamin D analogs with antiproliferative activities. Curr Pharm Des 6: 767\u2013789.","DOI":"10.2174\/1381612003400470"},{"key":"10.1124\/jpet.106.107599_bib32","doi-asserted-by":"crossref","unstructured":"Strober W, Fuss IJ, and Blumberg RS (2002) The immunology of mucosal models of inflammation. Annu Rev Immunol 20: 495\u2013549.","DOI":"10.1146\/annurev.immunol.20.100301.064816"},{"key":"10.1124\/jpet.106.107599_bib33","doi-asserted-by":"crossref","unstructured":"Szabo SJ, Sullivan BM, Peng SL, and Glimcher LH (2003) Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21: 713\u2013758.","DOI":"10.1146\/annurev.immunol.21.120601.140942"},{"key":"10.1124\/jpet.106.107599_bib34","doi-asserted-by":"crossref","unstructured":"Tocchini-Valentini G, Rochel N, Wurtz JM, and Moras D (2004) Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance: insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification. J Med Chem 47: 1956\u20131961.","DOI":"10.1021\/jm0310582"},{"key":"10.1124\/jpet.106.107599_bib35","doi-asserted-by":"crossref","unstructured":"Veldman CM, Cantorna MT, and DeLuca HF (2000) Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys 374: 334\u2013338.","DOI":"10.1006\/abbi.1999.1605"},{"key":"10.1124\/jpet.106.107599_bib36","doi-asserted-by":"crossref","unstructured":"Verlinden L, Verstuyf A, Quack M, Van CM, van EE, De CP, Vandewalle M, Carlberg C, and Bouillon R (2001) Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements. J Bone Miner Res 16: 625\u2013638.","DOI":"10.1359\/jbmr.2001.16.4.625"},{"key":"10.1124\/jpet.106.107599_bib37","doi-asserted-by":"crossref","unstructured":"Verstuyf A, Segaert S, Verlinden L, Bouillon R, and Mathieu C (2000) Recent developments in the use of vitamin D analogues. Expert Opin Investig Drugs 9: 443\u2013455.","DOI":"10.1517\/13543784.9.3.443"},{"key":"10.1124\/jpet.106.107599_bib38","doi-asserted-by":"crossref","unstructured":"Wallace JL and Keenan CM (1990) An orally active inhibitor of leukotriene synthesis accelerates healing in a rat model of colitis. Am J Physiol 258: G527\u2013G534.","DOI":"10.1152\/ajpgi.1990.258.4.G527"},{"key":"10.1124\/jpet.106.107599_bib39","doi-asserted-by":"crossref","unstructured":"Zella JB and DeLuca HF (2003) Vitamin D and autoimmune diabetes. J Cell Biochem 88: 216\u2013222.","DOI":"10.1002\/jcb.10347"},{"key":"10.1124\/jpet.106.107599_bib40","doi-asserted-by":"crossref","unstructured":"Zugel U, Steinmeyer A, Giesen C, and Asadullah K (2002) A novel immunosuppressive 1\u03b1,25-dihydroxyvitamin D3 analog with reduced hypercalcemic activity. J Investig Dermatol 119: 1434\u20131442.","DOI":"10.1046\/j.1523-1747.2002.19623.x"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524329945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524329945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.107599","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:03:02Z","timestamp":1740002582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524329945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["S0022356524329945"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.107599","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The New Low Calcemic Vitamin D Analog 22-Ene-25-Oxa-Vitamin D Prominently Ameliorates T Helper Cell Type 1-Mediated Colitis in Mice","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.107599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}